M Dumont
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Pancreatic and Hepatic Oncology Research
- Hepatology top 5%
Papers in
- Co-authors
- Serge Erlinger (31 shared papers)Daniel Dhumeaux (1 shared paper)P. Berthelot (1 shared paper)Emmanuel Jacquemin (5 shared papers)Olivier Bernard (3 shared papers)Danièle Cresteil (3 shared papers)Jean‐François Deleuze (1 shared paper)Claire Dubuisson (2 shared papers)
In The Last Decade
M Dumont
49 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 75
- Oncology 751
- Hepatology 168
- Surgery 600
- Pediatrics, Perinatology and Child Health 252
- Pharmacology 105
Countries citing papers authored by M Dumont
This map shows the geographic impact of M Dumont's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Dumont with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Dumont more than expected).
Fields of papers citing papers by M Dumont
This network shows the impact of papers produced by M Dumont. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Dumont. The network helps show where M Dumont may publish in the future.
Co-authors
The 25 scholars most cited alongside M Dumont, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 210 | |
| 2 | 1970 | 147 | |
| 3 | 1996 | 137 | |
| 4 | 1988 | 116 | |
| 5 | 1988 | 71 | |
| 6 | 1990 | 57 | |
| 7 | 1988 | 54 | |
| 8 | 1975 | 53 | |
| 9 | 1993 | 28 | |
| 10 | 1976 | 26 | |
| 11 | 1975 | 25 | |
| 12 | 1985 | 24 | |
| 13 | 1982 | 24 | |
| 14 | Cyclosporine-induced cholestasis: inhibition of bile acid secretion is caused by the parental molecule. | 1987 | 21 |
| 15 | 2010 | 15 | |
| 16 | 1971 | 14 | |
| 17 | Genetic cholestatic liver diseases: the example of progressive familial intrahepatic cholestasis and related disorders. | 2004 | 13 |
| 18 | 1985 | 12 | |
| 19 | 1989 | 12 | |
| 20 | 1991 | 11 |
About M Dumont
M Dumont is a scholar working on Oncology, Surgery, Pediatrics, Perinatology and Child Health, Epidemiology and Hepatology, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (22 papers), Pediatric Hepatobiliary Diseases and Treatments (14 papers), Liver Disease Diagnosis and Treatment (8 papers), Pharmacological Effects and Toxicity Studies (6 papers), Neonatal Health and Biochemistry (5 papers), Metabolism and Genetic Disorders (5 papers), Assisted Reproductive Technology and Twin Pregnancy (4 papers) and Liver Disease and Transplantation (4 papers). The work is most often cited by research in Oncology (751 citations), Hepatology (168 citations), Surgery (600 citations), Pediatrics, Perinatology and Child Health (252 citations) and Pharmacology (105 citations). M Dumont has collaborated with scholars based in France, Germany and Japan. Frequent co-authors include Serge Erlinger, Daniel Dhumeaux, P. Berthelot, Emmanuel Jacquemin, Olivier Bernard, Danièle Cresteil, Jean‐François Deleuze, Claire Dubuisson, Michelle Hadchouel and Laurent Combettes. Their work appears in journals such as American Journal of Physiology-Gastrointestinal and Liver Physiology, European Journal of Clinical Investigation, Fertility and Sterility, Digestive Diseases and Sciences and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.